• Users Online: 103
  • Print this page
  • Email this page


 
 
Table of Contents
LETTER TO THE EDITOR
Year : 2021  |  Volume : 12  |  Issue : 1  |  Page : 44-45

Dyslipidemia in adult thalassemia patients


Department of Medicine, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India

Date of Submission18-Oct-2020
Date of Acceptance18-Oct-2020
Date of Web Publication06-Jan-2021

Correspondence Address:
Dr. Shubha Laxmi Margekar
Room No. 1014, Department of Medicine, Lady Hardinge Medical College & SSKH, Panchkuin Road, New Delhi - 110 001
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/injms.injms_129_20

Rights and Permissions

How to cite this article:
Margekar SL, Sud R, Aggarwal R. Dyslipidemia in adult thalassemia patients. Indian J Med Spec 2021;12:44-5

How to cite this URL:
Margekar SL, Sud R, Aggarwal R. Dyslipidemia in adult thalassemia patients. Indian J Med Spec [serial online] 2021 [cited 2021 Jan 16];12:44-5. Available from: http://www.ijms.in/text.asp?2021/12/1/44/306250



Dear Editor,

Beta thalassemia is one of the most frequently seen autosomal recessive blood disorder. Over the past few decades, thalassemia has changed from fatal disease of early childhood to a chronic disease of adulthood. Regular blood transfusions and easy availability of iron chelation therapy have drastically improved the quality of life and increasing life expectancy into the third decade and beyond. Adult thalassemia patients have higher incidence of complications, which may be because of inadequate transfusions and/or chelation, transfusion-related complications such as viral infections, iron overload (hepatic, cardiac, and endocrine) and allosensitization, iron-chelator drug toxicities, osteoporosis and psychosocial issues.[1] Hence, awareness and knowledge are very important for physicians managing adult thalassemia individuals.

We read with interest the article on hypertriglyceridemia in thalassemia patient.[2] Dyslipidemia has been reported in various hematological disorders such as sickle cell disease, glucose-6-phosphate dehydrogenase deficiency, spherocytosis, aplastic anemia, myelodysplastic syndrome, and different types of beta thalassemia. Suggested mechanisms of pathogenesis[3],[4],[5] include:

  1. Plasma dilution due to anemia
  2. Increased cholesterol uptake by macrophages and histiocytes (of the reticuloendothelial system) due to accelerated erythropoiesis
  3. Iron overload leading to deranged liver function (decreased hepatic biosynthesis), resulting in altered lipoprotein pattern
  4. Cytokine release causing macrophage system activation
  5. Hormonal disturbances secondary to iron overload of endocrine organ systems
  6. Rise in circulating triglyceride because of decreased extra hepatic lipolytic activity.


Frequent blood transfusion leads to iron accumulation and overload in several organs namely heart, liver, and endocrine organs, and initiates hepatic acute-phase response. Therefore, with advancing age, the greater cumulative blood transfusions contribute to iron overload of several organs. Age in itself has a significant positive correlation with lipid values resulting in hypercholesterolemia and high low-density lipoprotein (LDL) cholesterol levels except that for high-density lipoprotein (HDL) cholesterol levels.[6] Several lifestyle factors such as dietary habits, smoking, glucose intolerance, and raised blood pressure specially, as thalassemia patients grow into adulthood affect the relationship between serum lipid profile levels and atherosclerotic changes. A significant decrease in total cholesterol, HDL-cholesterol, LDL-cholesterol values, lipoprotein (a) and apolipoproteins A1 and B has been reported in thalassemia patients, although triglycerides are found to be elevated.[6] In 192 young Greek thalassemia patients (average age males 25 years and females 26 years), total serum cholesterol values >200 mg/dL were observed in 4% males and 2% females, while hypertriglyceridemia (>150 mg/dL) was observed in 11% males and 17% females.

Higher the ratio of total cholesterol to HDL-cholesterol, more is the risk of thrombotic and atherosclerotic complications. Hypocholesterolemia and hypertriglyceridemia have been reported among thalassemia children as well.[7] The risk for myocardial infarction is also higher if HDL cholesterol is low, even with normal level of total cholesterol. Cardiac complications are the leading cause of mortality in patients of thalassemia. Cardiac damage occurs primarily because of iron overload resulting in thalassemic cardiomyopathy. Arrhythmias or sudden death may occur without any signs of cardiac disease in patients of thalassemia. The serum triglyceride values correlate negatively with RBCs transfusion index and have positive correlation with serum ferritin levels in thalassemia patients.

To conclude, deranged lipid profile makes the thalassemia subjects more prone for atherogenic and thrombotic complications. The factors contributing to dyslipidemia are mainly iron overload and oxidative stress. A regular follow-up and serum lipid profile should be done in all adult thalassemia patients for early detection and timely intervention. These patients with altered lipid profile should be on dietary and lifestyle modification, and pharmacological management, as and when needed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Prakash A, Aggarwal R. Thalassemia major in adults: Short stature, hyperpigmentation, inadequate chelation, and transfusion-transmitted infections are key features. N Am J Med Sci 2012;4:141-4.  Back to cited text no. 1
    
2.
Pandey S, Agrawal P, Rawat A, Gupta M, Khare P. Hypertriglyceridemia in a baby with thalassemia major. Indian J Med Spec 2020;11:157-60.  Back to cited text no. 2
  [Full text]  
3.
Ragab SM, Safan MA, Sherif AS. Lipid profiles in β thalassemic children. Menoufia Med J 2014;27:66-72.  Back to cited text no. 3
  [Full text]  
4.
Haghpanah S, Davani M, Samadi B, Ashrafi A, Karimi M. Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran. J Res Med Sci 2010;15:150-4.  Back to cited text no. 4
    
5.
Nasir C, Rosdiana N, Lubis AD. Correlation between 25-hydroxyvitamin D and lipid profile among children with beta thalassemia major. Open Access Maced J Med Sci 2018;6:1790-4.  Back to cited text no. 5
    
6.
Chrysohoou C, Panagiotakos DB, Pitsavos C, Kosma K, Barbetseas J, Karagiorga M, et al. Distribution of serum lipids and lipoproteins in patients with beta thalassaemia major; an epidemiological study in young adults from Greece. Lipids Health Dis 2004;3:3.  Back to cited text no. 6
    
7.
Doshi S, Sutay NR. Study of serum lipid profile in beta-thalassemia major patients. JMSCR 2016;4:11613-21. Available from: http://jmscr.igmpublication.org/v4-i7/71%20jmscr.pdf. [Last accessed on 2020 Oct 18].  Back to cited text no. 7
    




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed82    
    Printed3    
    Emailed0    
    PDF Downloaded9    
    Comments [Add]    

Recommend this journal